Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Gibbs

Showing results (491-500 of 515) with videos related to

Pageof 52
Sort By:
ESMO Real World Data and Digital Oncology|February 6, 2026
Real-world characteristics and outcomes of patients with BRAF<sup>V600E</sup>-mutant metastatic colorectal cancer in Australia: the COALA projectN Hitchen, H-L Wong, R Wong, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 2, 2017
Prognostic value of MACC1 and proficient mismatch repair status for recurrence risk prediction in stage II colon cancer patients: the BIOGRID studiesU-P Rohr, P Herrmann, K Ilm, et al.
Journal of the American College of Cardiology|October 23, 2012
Effects of AMG 145 on low-density lipoprotein cholesterol levels: results from 2 randomized, double-blind, placebo-controlled, ascending-dose phase 1 studies in healthy volunteers and hypercholesterolemic subjects on statinsClapton S Dias, Adam J Shaywitz, Scott M Wasserman, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 4, 2024
Pembrolizumab versus chemotherapy in microsatellite instability-high or mismatch repair-deficient metastatic colorectal cancer: 5-year follow-up from the randomized phase III KEYNOTE-177 studyT André, K-K Shiu, T W Kim, et al.
Arthritis and Rheumatism|July 13, 2002
Hydroxychloroquine concentration-response relationships in patients with rheumatoid arthritisTino Munster, John P Gibbs, Danny Shen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 13, 2012
Association of hypomagnesemia with inferior survival in a phase III, randomized study of cetuximab plus best supportive care versus best supportive care alone: NCIC CTG/AGITG CO.17M M Vickers, C S Karapetis, D Tu, et al.
PNAS Nexus|August 24, 2023
Anthropogenic uranium signatures in turtles, tortoises, and sea turtles from nuclear sitesCyler Conrad, Jeremy Inglis, Allison Wende, et al.
The British Journal of Surgery|August 20, 2019
Secondary technical resectability of colorectal cancer liver metastases after chemotherapy with or without selective internal radiotherapy in the randomized SIRFLOX trialB Garlipp, P Gibbs, G A Van Hazel, et al.
ESMO Real World Data and Digital Oncology|February 6, 2026
Impact of neoadjuvant FOLFIRINOX over upfront resection in borderline resectable pancreatic cancer-an international, multicentre, real-world analysisS Banks, W Hong, K Degeling, et al.
British Journal of Pharmacology|September 11, 2014
Preclinical development of AMG 139, a human antibody specifically targeting IL-23K Köck, W J Pan, J M Gow, et al.
Pageof 52

Showing results (491-500 of 515) with videos related to

Sort By:
Pageof 52
ESMO Real World Data and Digital Oncology|February 6, 2026
Real-world characteristics and outcomes of patients with BRAF<sup>V600E</sup>-mutant metastatic colorectal cancer in Australia: the COALA projectN Hitchen, H-L Wong, R Wong, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 2, 2017
Prognostic value of MACC1 and proficient mismatch repair status for recurrence risk prediction in stage II colon cancer patients: the BIOGRID studiesU-P Rohr, P Herrmann, K Ilm, et al.
Journal of the American College of Cardiology|October 23, 2012
Effects of AMG 145 on low-density lipoprotein cholesterol levels: results from 2 randomized, double-blind, placebo-controlled, ascending-dose phase 1 studies in healthy volunteers and hypercholesterolemic subjects on statinsClapton S Dias, Adam J Shaywitz, Scott M Wasserman, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 4, 2024
Pembrolizumab versus chemotherapy in microsatellite instability-high or mismatch repair-deficient metastatic colorectal cancer: 5-year follow-up from the randomized phase III KEYNOTE-177 studyT André, K-K Shiu, T W Kim, et al.
Arthritis and Rheumatism|July 13, 2002
Hydroxychloroquine concentration-response relationships in patients with rheumatoid arthritisTino Munster, John P Gibbs, Danny Shen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 13, 2012
Association of hypomagnesemia with inferior survival in a phase III, randomized study of cetuximab plus best supportive care versus best supportive care alone: NCIC CTG/AGITG CO.17M M Vickers, C S Karapetis, D Tu, et al.
PNAS Nexus|August 24, 2023
Anthropogenic uranium signatures in turtles, tortoises, and sea turtles from nuclear sitesCyler Conrad, Jeremy Inglis, Allison Wende, et al.
The British Journal of Surgery|August 20, 2019
Secondary technical resectability of colorectal cancer liver metastases after chemotherapy with or without selective internal radiotherapy in the randomized SIRFLOX trialB Garlipp, P Gibbs, G A Van Hazel, et al.
ESMO Real World Data and Digital Oncology|February 6, 2026
Impact of neoadjuvant FOLFIRINOX over upfront resection in borderline resectable pancreatic cancer-an international, multicentre, real-world analysisS Banks, W Hong, K Degeling, et al.
British Journal of Pharmacology|September 11, 2014
Preclinical development of AMG 139, a human antibody specifically targeting IL-23K Köck, W J Pan, J M Gow, et al.
Pageof 52